Juliet Bakker

Managing Director, Longitude Capital

Ms. Bakker is a Managing Director and Founder of Longitude Capital. Prior to Longitude Capital, Ms. Bakker was a Managing Director of Pequot Ventures, where she founded the life sciences investment practice. Prior to Pequot, she was Director, Strategic Planning and Director, Operations of Waste Management International, and was a sell-side equity analyst with Banque Paribas. Ms. Bakker began her career as an investment banker in the corporate finance department at Paine Webber. She currently serves on the boards of Ceribell, Endogenex, Nalu, RxSight (RXST), and Sydnexis. Selected prior board memberships include Ablation Frontiers (acquired by Medtronic), Alphaeon, AqueSys (acquired by Allergan), Axonics Modulation Technologies (AXNX), CryoVascular Systems (acquired by Boston Scientific), Eargo (EAR), Embolic Protection (acquired by Boston Scientific), Enteric Medical (acquired by Boston Scientific), eyeonics(acquired by Bausch+Lomb), Genyx Medical (acquired by C.R. Bard), Insulet (PODD), Precision Dermatology (acquired by Valeant Pharmaceuticals), Sadra Medical (acquired by Boston Scientific), and Venus Concept (VERO). Ms. Bakker holds an MPA from the Harvard Kennedy School and a BSc from the College of Agriculture and Life Sciences (”CALS”) at Cornell University, where she is a member of the CALS Advisory Council.

Focus Areas: Medical Technology, Health Solutions

Location: Greenwich